Genetics of type 2 diabetes

Endocrine Development

Volumn 31, Issue , 2016, Pages 203-220

  Stančáková, Alena ^a   Laakso, Markku ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HISTONE;

ARTICLE; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIGENETICS; EXOME; GENE IDENTIFICATION; GENE INTERACTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOME; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HISTONE MODIFICATION; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; LINKAGE ANALYSIS; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; DIABETES MELLITUS, TYPE 2; ENVIRONMENT; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY;

DIABETES MELLITUS, TYPE 2; ENVIRONMENT; EPIGENESIS, GENETIC; EXOME; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS;

EID: 84956615313     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000439418     Document Type: Article

References (104)

1. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications
2. International Diabetes Federation: IDF Diabetes Atlas, ed 5. Brussels, Belgium, International Diabetes Federation, 2011.
3. Alberti G, Zimmet P, Shaw J, et al. Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care. 2004; 27: 1798-1811.
4. Mykkänen L, Kuusisto J, Pyörälä K, et al. Cardiovascular disease risk factors as predictors of type 2 (noninsulin-dependent) diabetes mellitus in elderly subjects. Diabetologia. 1993; 36: 553-559.
5. Kaprio J, Tuomilehto J, Koskenvuo M, et al. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia. 1992; 35: 1060-1067.
6. Diamond J. The double puzzle of diabetes. Nature. 2003; 423: 599-602.
7. Köbberling J, Tillil H. Empirical risk figures for firstdegree relatives of noninsulin dependent diabetics; in Köbberling J, Tattersall R (eds): The Genetics of Diabetes Mellitus. London, Academic Press, 1982, pp 201-209.
8. Schork NJ, Murray SS, Frazer KA, et al. Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev. 2009; 19: 212-219.
9. Neel JV. Diabetes mellitus: a thrifty genotype rendered detrimental by progress?. Am J Hum Genet. 1962; 14: 353-362.
10. Barton NH, Turelli M. Evolutionary quantitative genetics: how little do we know?. Annu Rev Genet. 1989; 23: 337-370.
11. Vaxillaire M, Froguel P. Genetic basis of maturityonset diabetes of the young. Endocrinol Metab Clin North Am. 2006; 35: 371-384.
12. Horikawa Y, Oda N, Cox NJ, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet. 2000; 26: 163-175.
13. Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006; 38: 320-323.
14. Reynisdottir I, Thorleifsson G, Benediktsson R, et al. Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. Am J Hum Genet. 2003; 73: 323-335.
15. Rulifson IC, Karnik SK, Heiser PW, et al. Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci U S A. 2007; 104: 6247-652.
16. Yen CJ, Beamer BA, Negri C, et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun. 1997; 241: 270-274.
17. Deeb SS, Fajas L, Nemoto M, et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 1998; 20: 284-287.
18. Altshuler D, Hirschhorn JN, Klannemark M, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000; 26: 76-80.
19. Zeggini E, Weedon MN, Lindgren CM, et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007; 316: 1336-1341.
20. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research, Saxena R, Voight BF, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007; 316: 1331-1336.
21. Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007; 316: 1341-1345.
22. Gloyn AL, Pearson ER, Antcliff JF, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med. 2004; 350: 1838-1849.
23. Hani EH, Boutin P, Durand E, et al. Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-Analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians. Diabetologia. 1998; 41: 1511-1515.
24. Gloyn AL, Hashim Y, Ashcroft SJ, et al. Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53). Diabet Med. 2001; 18: 206-212.
25. Schwanstecher C, Schwanstecher M. Nucleotide sensitivity of pancreatic ATP-sensitive potassium channels and type 2 diabetes. Diabetes. 2002; 51(suppl 3): S358-S362.
26. Almind K, Bjørbaek C, Vestergaard H, et al. Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet. 1993; 342: 828-832.
27. Minton JA, Hattersley AT, Owen K, et al. Association studies of genetic variation in the WFS1 gene and type 2 diabetes in U.K. populations. Diabetes. 2002; 51: 1287-1290.
28. Bonnycastle LL, Willer CJ, Conneely KN, et al. Common variants in maturity-onset diabetes of the young genes contribute to risk of type 2 diabetes in Finns. Diabetes. 2006; 55: 2534-2540.
29. International HapMap Consortium: The International HapMap Project. Nature 2003 426 789-796.
30. International HapMap Consortium: A haplotype map of the human genome. Nature 2005 437 1299-1320.
31. 1000 Genomes Project Consortium, Abecasis GR, Altshuler D, et al. A map of human genome variation from population-scale sequencing. Nature. 2010; 467: 1061-1073.
32. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007; 445: 881-885.
33. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007; 39: 770-775.
34. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007; 316: 889-894.
35. Unoki H, Takahashi A, Kawaguchi T, et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet. 2008; 40: 1098-1102.
36. Yamauchi T, Hara K, Maeda S, et al. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat Genet. 2010; 42: 864-868.
37. Rung J, Cauchi S, Albrechtsen A, et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet. 2009; 41: 1110-1115.
38. Qi L, Cornelis MC, Kraft P, et al. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet. 2010; 19: 2706-2715.
39. Zeggini E, Scott LJ, Saxena R, et al. Meta-Analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008; 40: 638-645.
40. Prokopenko I, Langenberg C, Florez JC, et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet. 2009; 41: 77-81.
41. Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010; 42: 579-589.
42. Morris AP, Voight BF, Teslovich TM, et al. Largescale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012; 44: 981-990.
43. Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010; 42: 105-116.
44. Saxena R, Hivert MF, Langenberg C, et al. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet. 2010; 42: 142-148.
45. Scott RA, Lagou V, Welch RP, et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet. 2012; 44: 991-1005.
46. Soranzo N, Sanna S, Wheeler E, et al. Common variants at 10 genomic loci influence hemoglobin A1(C) levels via glycemic and nonglycemic pathways. Diabetes. 2010; 59: 3229-3239.
47. Strawbridge RJ, Dupuis J, Prokopenko I, et al. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes. 2011; 60: 2624-2634.
48. Ingelsson E, Langenberg C, Hivert MF, et al. Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes. 2010; 59: 1266-1275.
49. Dimas AS, Lagou V, Barker A, et al. Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes. 2014; 63: 2158-2171.
50. Lehtovirta M, Kaprio J, Forsblom C, et al. Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins. Diabetologia. 2000; 43: 285-293.
51. Manning AK, Hivert MF, Scott RA, et al. A genomewide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet. 2012; 44: 659-669.
52. Kooner JS, Saleheen D, Sim X, et al. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet. 2011; 43: 984-989.
53. Cho YS, Chen CH, Hu C, et al. Meta-Analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet. 2011; 44: 67-72.
54. Tsai FJ, Yang CF, Chen CC, et al. A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genet. 2010; 6: e1000847.
55. Shu XO, Long J, Cai Q, et al. Identification of new genetic risk variants for type 2 diabetes. PLoS Genet. 2010; 6: e1001127.
56. Tabassum R, Chauhan G, Dwivedi OP, et al. Genome-wide association study for type 2 diabetes in Indians identifies a new susceptibility locus at 2q21. Diabetes. 2013; 62: 977-986.
57. Hara K, Fujita H, Johnson TA, et al. Genome-wide association study identifies three novel loci for type 2 diabetes. Hum Mol Genet. 2014; 23: 239-246.
58. Ma RC, Hu C, Tam CH, et al. Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4. Diabetologia. 2013; 56: 1291-1305.
59. Imamura M, Maeda S, Yamauchi T, et al. A singlenucleotide polymorphism in ANK1 is associated with susceptibility to type 2 diabetes in Japanese populations. Hum Mol Genet. 2012; 21: 3042-3049.
60. Li H, Gan W, Lu L, et al. A genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese Hans. Diabetes. 2013; 62: 291-298.
61. Palmer ND, McDonough CW, Hicks PJ, et al. A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One. 2012; 7: e29202.
62. Hanson RL, Bogardus C, Duggan D, et al. A search for variants associated with young-onset type 2 diabetes in American Indians in a 100K genotyping array. Diabetes. 2007; 56: 3045-3052.
63. SIGMA Type 2 Diabetes Consortium, Williams AL, Jacobs SB, et al. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature. 2014; 506: 97-101.
64. DIAbetes Genetics Replication And Meta-Analysis (DIAGRAM) Consortium: Genome-wide trans-Ancestry meta-Analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet 2014 46 234-244.
65. Saxena R, Elbers CC, Guo Y, et al. Large-scale genecentric meta-Analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet. 2012; 90: 410-425.
66. Carlson CS, Matise TC, North KE, et al. Generalization and dilution of association results from European GWAS in populations of non-European ancestry: the PAGE study. PLoS Biol. 2013; 11: e1001661.
67. Waters KM, Stram DO, Hassanein MT, et al. Consistent association of type 2 diabetes risk variants found in Europeans in diverse racial and ethnic groups. PLoS Genet. 2010; 6: e1001078.
68. Zuk O, Hechter E, Sunyaev SR, et al. The mystery of missing heritability: Genetic interactions create phantom heritability. Proc Natl Acad Sci U S A. 2012; 109: 1193-1198.
69. Lohmueller KE, Sparsø T, Li Q, et al. Whole-exome sequencing of 2, 000 Danish individuals and the role of rare coding variants in type 2 diabetes. Am J Hum Genet. 2013; 93: 1072-1086.
70. Huyghe JR, Jackson AU, Fogarty MP, et al. Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion. Nat Genet. 2013; 45: 197-201.
71. Bonnefond A, Clément N, Fawcett K, et al. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet. 2012; 44: 297-301.
72. Korbel JO, Urban AE, Affourtit JP, et al. Paired-end mapping reveals extensive structural variation in the human genome. Science. 2007; 318: 420-426.
73. Wellcome Trust Case Control Consortium, Craddock N, Hurles ME, et al. Genome-wide association study of CNVs in 16, 000 cases of eight common diseases and 3, 000 shared controls. Nature. 2010; 464: 713-720.
74. McCarthy MI, Hirschhorn JN. Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet. 2008; 17: R156-R165.
75. Franks PW, Mesa JL, Harding AH, et al. Gene-lifestyle interaction on risk of type 2 diabetes. Nutr Metab Cardiovasc Dis. 2007; 17: 104-124.
76. Brito EC, Lyssenko V, Renström F, et al. Previously associated type 2 diabetes variants may interact with physical activity to modify the risk of impaired glucose regulation and type 2 diabetes: a study of 16, 003 Swedish adults. Diabetes. 2009; 58: 1411-1418.
77. Sonestedt E, Lyssenko V, Ericson U, et al. Genetic variation in the glucose-dependent insulinotropic polypeptide receptor modifies the association between carbohydrate and fat intake and risk of type 2 diabetes in the Malmo Diet and Cancer cohort. J Clin Endocrinol Metab. 2012; 97: E810-E818.
78. Cornelis MC, Qi L, Kraft P, et al. TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women. Am J Clin Nutr. 2009; 89: 1256-1262.
79. Wolffe AP, Guschin D. Review: chromatin structural features and targets that regulate transcription. J Struct Biol. 2000; 129: 102-122.
80. Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes. 2000; 49: 2208-2211.
81. Drong AW, Lindgren CM, McCarthy MI. The genetic and epigenetic basis of type 2 diabetes and obesity. Clin Pharmacol Ther. 2012; 92: 707-715.
82. Nilsson E, Jansson PA, Perfilyev A, et al. Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes. Diabetes. 2014; 63: 2962-2976.
83. Dayeh T, Volkov P, Salö S, et al. Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion. PLoS Genet. 2014; 10: e1004160.
84. Toperoff G, Aran D, Kark JD, et al. Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum Mol Genet. 2012; 21: 371-383.
85. Rönn T, Volkov P, Davegårdh C, et al. A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue. PLoS Genet. 2013; 9: e1003572.
86. Vänttinen M, Nuutila P, Kuulasmaa T, et al. Single nucleotide polymorphisms in the peroxisome proliferator-Activated receptor delta gene are associated with skeletal muscle glucose uptake. Diabetes. 2005; 54: 3587-3591.
87. Rane SG, Dubus P, Mettus RV, et al. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet. 1999; 22: 44-52.
88. Kasper JS, Giovannucci E. A meta-Analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006; 15: 2056-2062.
89. Myers SA, Nield A, Myers M. Zinc transporters, mechanisms of action and therapeutic utility: implications for type 2 diabetes mellitus. J Nutr Metab. 2012; 2012: 173712.
90. Nagorny C, Lyssenko V. Tired of diabetes genetics?. Circadian rhythms and diabetes: the MTNR1B story?. Curr Diab Rep. 2012; 12: 667-672.
91. Willer CJ, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008; 40: 161-169.
92. Lemaitre RN, Tanaka T, Tang W, et al. Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-Analysis of genome-wide association studies from the CHARGE Consortium. PLoS Genet. 2011; 7: e1002193.
93. Chambers JC, Zhang W, Sehmi J, et al. Genomewide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet. 2011; 43: 1131-1138.
94. Speliotes EK, Yerges-Armstrong LM, Wu J, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 2011; 7: e1001324.
95. OSeaghdha CM, Wu H, Yang Q, et al. Meta-Analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations. PLoS Genet. 2013; 9: e1003796.
96. Coviello AD, Haring R, Wellons M, et al. A genomewide association meta-Analysis of circulating sex hormone-binding globulin reveals multiple loci implicated in sex steroid hormone regulation. PLoS Genet. 2012; 8: e1002805.
97. Dehghan A, Dupuis J, Barbalic M, et al. Meta-Analysis of genome-wide association studies in 80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation. 2011; 123: 731-738.
98. Köttgen A, Pattaro C, Böger CA, et al. New loci associated with kidney function and chronic kidney disease. Nat Genet. 2010; 42: 376-384.
99. Kolz M, Johnson T, Sanna S, et al. Meta-Analysis of 28, 141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 2009; 5: e1000504.
100. Stan?áková A, Paananen J, Soininen P, et al. Effects of 34 risk loci for type 2 diabetes or hyperglycemia on lipoprotein subclasses and their composition in 6, 580 nondiabetic Finnish men. Diabetes. 2011; 60: 1608-1616.
101. Stan?áková A, Civelek M, Saleem NK, et al. Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9, 369 Finnish men. Diabetes. 2012; 61: 1895-1902.
102. Mahendran Y, Vangipurapu J, Cederberg H, et al. Association of ketone body levels with hyperglycemia and type 2 diabetes in 9, 398 Finnish men. Diabetes. 2013; 62: 3618-3626.
103. de la Iglesia N, Mukhtar M, Seoane J, et al. The role of the regulatory protein of glucokinase in the glucose sensory mechanism of the hepatocyte. J Biol Chem. 2000; 275: 10597-10603.
104. Lyssenko V, Laakso M. Genetic screening for the risk of type 2 diabetes: worthless or valuable?. Diabetes Care. 2013; 36(suppl 2): S120-S126.